Cargando…
National and provincial impact and cost-effectiveness of Haemophilus influenzae type b conjugate vaccine in China: a modeling analysis
BACKGROUND: Globally, Haemophilus influenzae type b (Hib) vaccine has substantially reduced the burden of Hib invasive disease. However, China remains the only country not to include Hib vaccine into its national immunization program (NIP), although it accounts for 11% of global Hib deaths. We aimed...
Autores principales: | Zhang, Haijun, Garcia, Cristina, Yu, Wenzhou, Knoll, Maria Deloria, Lai, Xiaozhen, Xu, Tingting, Jing, Rize, Qin, Ying, Yin, Zundong, Wahl, Brian, Fang, Hai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8356460/ https://www.ncbi.nlm.nih.gov/pubmed/34376214 http://dx.doi.org/10.1186/s12916-021-02049-7 |
Ejemplares similares
-
National, regional, and provincial disease burden attributed to Streptococcus pneumoniae and Haemophilus influenzae type b in children in China: Modelled estimates for 2010–17
por: Lai, Xiaozhen, et al.
Publicado: (2022) -
Estimating national, regional and provincial cost-effectiveness of introducing childhood 13-valent pneumococcal conjugate vaccination in China: a modelling analysis
por: Lai, Xiaozhen, et al.
Publicado: (2022) -
Acceptance of COVID-19 Vaccination during the COVID-19 Pandemic in China
por: Wang, Jiahao, et al.
Publicado: (2020) -
Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000–15
por: Wahl, Brian, et al.
Publicado: (2018) -
Willingness to pay and financing preferences for COVID-19 vaccination in China
por: Wang, Jiahao, et al.
Publicado: (2021)